Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gerber

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-WorkshopB Ultsch, O Damm, P Beutels, et al.
Pediatric Blood & Cancer|March 13, 2026
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 StudyDaniel A Morgenstern, Giuseppe Barone, Nadege Corradini, et al.
Cancers|March 12, 2020
Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell BiologyGabriele Calaminus, Dominik T Schneider, Dietrich von Schweinitz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2020
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancerLucas Moreno, Michela Casanova, Julia C Chisholm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 5, 2021
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
BMC Medicine|May 19, 2026
Generative AI for spatial tumor growth on MRI: a proof-of-principle study in pediatric diffuse midline gliomaDaria Laslo, Julia Wolleb, Maria Monzon, et al.
Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-WorkshopB Ultsch, O Damm, P Beutels, et al.
Pediatric Blood & Cancer|March 13, 2026
Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 StudyDaniel A Morgenstern, Giuseppe Barone, Nadege Corradini, et al.
Cancers|March 12, 2020
Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell BiologyGabriele Calaminus, Dominik T Schneider, Dietrich von Schweinitz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2020
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancerLucas Moreno, Michela Casanova, Julia C Chisholm, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 5, 2021
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
BMC Medicine|May 19, 2026
Generative AI for spatial tumor growth on MRI: a proof-of-principle study in pediatric diffuse midline gliomaDaria Laslo, Julia Wolleb, Maria Monzon, et al.
Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Pageof 19